Capricor Therapeutics, Inc. financial data

Symbol
CAPR on Nasdaq
Location
8840 Wilshire Blvd, 2 Nd Floor, Beverly Hills, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 535 % +158%
Debt-to-equity 26.5 % -73%
Return On Equity -71 % +37.1%
Return On Assets -56.1 % +1.51%
Operating Margin -191 % -99.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares +0.55%
Common Stock, Shares, Outstanding 45.7M shares +13.4%
Entity Public Float 140M USD +17%
Common Stock, Value, Issued 45.7K USD +13.4%
Weighted Average Number of Shares Outstanding, Basic 45.7M shares +38.2%
Weighted Average Number of Shares Outstanding, Diluted 45.7M shares +38.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 22.3M USD -11.5%
Research and Development Expense 75.9M USD +67.3%
General and Administrative Expense 21.9M USD +56.4%
Operating Income (Loss) -86.7M USD -140%
Nonoperating Income (Expense) 4.69M USD +131%
Net Income (Loss) Attributable to Parent -82M USD -140%
Earnings Per Share, Basic -1 USD/shares -71.6%
Earnings Per Share, Diluted -1 USD/shares -71.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.5M USD -71.5%
Marketable Securities, Current 79.1M USD +375%
Cash, Cash Equivalents, and Short-term Investments 98.6M USD +16%
Assets, Current 101M USD +17.6%
Property, Plant and Equipment, Net 11.1M USD +108%
Operating Lease, Right-of-Use Asset 13.9M USD +833%
Assets 126M USD +36%
Accounts Payable, Current 2.72M USD
Employee-related Liabilities, Current 4.73M USD
Accrued Liabilities, Current 9.93M USD
Contract with Customer, Liability, Current 12M USD -8.61%
Liabilities, Current 28.1M USD +37.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 14.4M USD +1627%
Liabilities 42.6M USD +72.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 844K USD +777%
Retained Earnings (Accumulated Deficit) -275M USD -42.5%
Stockholders' Equity Attributable to Parent 83.9M USD +22.9%
Liabilities and Equity 126M USD +36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.43M USD -407%
Net Cash Provided by (Used in) Financing Activities 50.4K USD -97.8%
Net Cash Provided by (Used in) Investing Activities 23.9M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 45.7M shares +13.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.5M USD -71.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Operating Lease, Liability 14.5M USD +782%
Depreciation 1.76M USD +29.8%
Payments to Acquire Property, Plant, and Equipment 896K USD +47.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -81.2M USD -138%
Lessee, Operating Lease, Liability, to be Paid 19.1M USD +974%
Property, Plant and Equipment, Gross 15.7M USD +83.7%
Operating Lease, Liability, Current 120K USD -85.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.41M USD +280%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.12M USD +22.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure -13.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.53M USD +3463%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.48M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.56M USD
Operating Lease, Payments 923K USD +9.48%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 405K USD +22.3%
Share-based Payment Arrangement, Expense 15.7M USD +68%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%